Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Steffen Goletz
Phase I Study of Tomuzotuximab, a Glycoengineered Therapeutic Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Carcinomas
ESMO Open
Cancer Research
Oncology
What Makes Cancer Stem Cell Markers Different?
SpringerPlus
Multidisciplinary
Related publications
Monoclonal Antibody Against Epidermal Growth Factor Receptor Is Internalized Without Stimulating Receptor Phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
First-In-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-Her3 Monoclonal Antibody, in Patients With Metastatic or Advanced HER3-Positive Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Therapeutic Potential of Epidermal Growth Factor Receptor-Related Protein
Molecular Cancer Therapeutics
Cancer Research
Oncology
First-In-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients With Advanced Hepatocellular Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study
Biomedical Journal
Medicine
A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Immunohistochemical Expression of the Promising Therapeutic Target (Human Epidermal Growth Factor Receptor 2/Neu) in Iraqi Patients With Medulloblastoma
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology